PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Hologic, Inc. (HOLX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS4364401012
CUSIP436440101
SectorHealthcare
IndustryMedical Instruments & Supplies

Highlights

Market Cap$18.30B
EPS$2.11
PE Ratio36.95
PEG Ratio1.46
Revenue (TTM)$3.97B
Gross Profit (TTM)$2.48B
EBITDA (TTM)$1.25B
Year Range$64.02 - $87.88
Target Price$84.50
Short %2.96%
Short Ratio2.49

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Hologic, Inc.

Popular comparisons: HOLX vs. ZBH, HOLX vs. FAT, HOLX vs. VOO, HOLX vs. BRK-B, HOLX vs. MDT, HOLX vs. ISRG, HOLX vs. LLY, HOLX vs. PFE, HOLX vs. AMAGX, HOLX vs. CHD

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Hologic, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2024FebruaryMarchApril
10.47%
17.40%
HOLX (Hologic, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Hologic, Inc. had a return of 4.86% year-to-date (YTD) and -9.20% in the last 12 months. Over the past 10 years, Hologic, Inc. had an annualized return of 13.70%, outperforming the S&P 500 benchmark which had an annualized return of 10.43%.


PeriodReturnBenchmark
Year-To-Date4.86%5.29%
1 month-1.87%-2.47%
6 months10.32%16.40%
1 year-9.20%20.88%
5 years (annualized)11.57%11.60%
10 years (annualized)13.70%10.43%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20244.18%-0.86%5.64%
2023-7.14%-4.65%7.75%0.21%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of HOLX is 27, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of HOLX is 2727
Hologic, Inc.(HOLX)
The Sharpe Ratio Rank of HOLX is 2424Sharpe Ratio Rank
The Sortino Ratio Rank of HOLX is 2222Sortino Ratio Rank
The Omega Ratio Rank of HOLX is 2424Omega Ratio Rank
The Calmar Ratio Rank of HOLX is 2727Calmar Ratio Rank
The Martin Ratio Rank of HOLX is 3838Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Hologic, Inc. (HOLX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


HOLX
Sharpe ratio
The chart of Sharpe ratio for HOLX, currently valued at -0.54, compared to the broader market-2.00-1.000.001.002.003.00-0.54
Sortino ratio
The chart of Sortino ratio for HOLX, currently valued at -0.68, compared to the broader market-4.00-2.000.002.004.00-0.68
Omega ratio
The chart of Omega ratio for HOLX, currently valued at 0.92, compared to the broader market0.501.001.500.92
Calmar ratio
The chart of Calmar ratio for HOLX, currently valued at -0.41, compared to the broader market0.001.002.003.004.005.00-0.41
Martin ratio
The chart of Martin ratio for HOLX, currently valued at -0.68, compared to the broader market0.0010.0020.0030.00-0.68
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.79, compared to the broader market-2.00-1.000.001.002.003.001.79
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.61, compared to the broader market-4.00-2.000.002.004.002.61
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.31
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.001.002.003.004.005.001.36
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.21, compared to the broader market0.0010.0020.0030.007.21

Sharpe Ratio

The current Hologic, Inc. Sharpe ratio is -0.54. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.54
1.79
HOLX (Hologic, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Hologic, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2024FebruaryMarchApril
-14.54%
-4.42%
HOLX (Hologic, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Hologic, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hologic, Inc. was 93.75%, occurring on Oct 21, 1999. Recovery took 1478 trading sessions.

The current Hologic, Inc. drawdown is 14.54%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.75%Jun 26, 1996839Oct 21, 19991478Sep 8, 20052317
-87.61%Jul 17, 1990862Dec 15, 1993480Nov 8, 19951342
-73.65%Dec 27, 2007301Mar 9, 20091567May 29, 20151868
-46.24%Jan 30, 202037Mar 23, 202062Jun 19, 202099
-35.83%Apr 3, 200649Jun 12, 2006160Jan 31, 2007209

Volatility

Volatility Chart

The current Hologic, Inc. volatility is 5.72%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%NovemberDecember2024FebruaryMarchApril
5.72%
3.35%
HOLX (Hologic, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Hologic, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items